Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their Disease

Despite the growing evidence of the clinical value of somatostatin receptor (SSTR) positron emission tomography (PET) in the evaluation of neuroendocrine tumors (NETs), its role remains to be clarified at different time points in the journey of patients with multiple endocrine neoplasia type 1 (MEN1...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The journal of clinical endocrinology and metabolism 2022-05, Vol.107 (5), p.e2056-e2064
Hauptverfasser:	Mennetrey, Clément, Le Bras, Maëlle, Bando-Delaunay, Aurélie, Al-Mansour, Laure, Haissaguerre, Magalie, Batisse-Lignier, Marie, Ouvrard, Eric, Ansquer, Catherine, Walter, Thomas, de Mestier, Louis, Kelly, Antony, Tlili, Ghoufrane, Giraud, Sophie, North, Marie-Odile, Odou, Marie-Françoise, Goichot, Bernard, Cuny, Thomas, Loundou, Anderson, Romanet, Pauline, Imperiale, Alessio, Taïeb, David
Format:	Artikel
Sprache:	eng
Schlagworte:	Care and treatment CT imaging Human health and pathology Humans Life Sciences Metastasis Multiple Endocrine Neoplasia Type 1 - diagnostic imaging Neuroendocrine Tumors - diagnostic imaging PET imaging Positron Emission Tomography Computed Tomography - methods Positron-Emission Tomography - methods Prospective Studies Radiotherapy Receptors, Somatostatin Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!